Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KínaPercutaneous Pulsed Electric Field Ablation for Early-Stage NSCLC and Lung Oligometastases: A Safety and Efficacy Study
- Where
- Guangzhou
- Életkor
- 18 év to 79 év
- People
- 10
- Run by
- Energenx Medical LTD.
See details and how to joinNCT07799194 - No phaseTaking peopleThe Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms
- Where
- Chengdu
- Életkor
- 18 év to 85 év
- People
- 126
- Run by
- West China Hospital
See details and how to joinNCT07310056 - No phaseNot yet taking people in KínaTROP2 NMR Concordance Study
- Where
- Beijing, Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 3400
- Run by
- AstraZeneca
See details and how to joinNCT07624318 - No phaseTaking peopleStation 4L Lymph Node Dissection Versus No Dissection in Clinical Stage I Solid Nodule-Type Invasive NSCLC
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 384
- Run by
- Fudan University
See details and how to joinNCT07801430 - No phaseTaking peopleWireless Wearable Home Prehabilitation for Older Adults With NSCLC
- Where
- Chengdu
- Életkor
- 65 év to 85 év
- People
- 196
- Run by
- West China Hospital
See details and how to joinNCT07809763 - 1/2. fázisTaking peopleA Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
- Where
- Anyang, Beijing, Cangzhou, Changsha, Chengdu, Chongqing, Dalian, Guangzhou, Guanzhou, Hangzhou, Harbin, Jinan, Linyi, Luoyang, Nanchang, Nanjin, Nanjing, Nanning, Nanyang, Shanghai, Shenyang, Taiyuan, Taizhou, Tianjin, Wuhan, Xi’an, Yangzhou, Zhongshan
- Életkor
- 18 év to 75 év
- People
- 465
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07367529 - 1. fázisNot yet taking people in KínaPhase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- Beijing Anjianxi Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07806500 - No phaseTaking peopleReal World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer
- Where
- Beijing, Shanghai
- Életkor
- 18 év and over
- People
- 2572
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07806604 - No phaseTaking peopleOlive Oil Before Lung Cancer Surgery to Prevent Chylothorax
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 1036
- Run by
- Fudan University
See details and how to joinNCT07807696 - 2. fázisNot yet taking people in KínaNeoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 29
- Run by
- Hubei Cancer Hospital
See details and how to joinNCT07807722 - No phaseTaking peopleSmartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer
- Where
- Zhongshan
- Életkor
- 18 év to 75 év
- People
- 736
- Run by
- Zhongshan People's Hospital, Guangdong, China
See details and how to joinNCT05990946 - 1. fázisTaking peopleA Phase I Study of CFT8919 in Patients With Advanced NSCLC
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 166
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT06641609 - No phaseTaking peopleStaging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces
- Where
- Changsha
- People
- 500
- Run by
- Central South University
See details and how to joinNCT07066813 - Korai 1. fázisTaking peopleThe Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
- Where
- Wuxi
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07459283 - No phaseTaking peopleMDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients
- Where
- Chengdu
- Életkor
- 60 év to 90 év
- People
- 2000
- Run by
- West China Hospital
See details and how to joinNCT07509333 - 1. fázisTaking peopleA Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Where
- Beijing, Haerbin, Linyi, Shanghai
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT04913285 - No phaseTaking peopleAssessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 180
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT05559645 - 1/2. fázisTaking peopleStudy of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
- Where
- Shanghai, Tianjin
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06567015 · EU 2023-510203-21-00 - No phaseTaking peopleZusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
- Where
- Chengdu
- Életkor
- 18 év to 80 év
- People
- 82
- Run by
- West China Hospital
See details and how to joinNCT07076836 - 2. fázisTaking peopleThe Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients
- Where
- Changsha, Hengyang, Jishou
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- The Third Xiangya Hospital of Central South University
See details and how to joinNCT07138755 - 2. fázisTaking peopleA Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
See details and how to joinNCT07562581 - 2. fázisTaking peopleA Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Guilin, Hangzhou, Harbin, Jinan, Kunming, Nanchang, Nanjing, Nanning, Shenyang, Taiyuan, Tianjin, Ürümqi, Xiamen, Xi’an, Xiangyang, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 150
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
See details and how to joinNCT07622186 - No phaseNot yet taking people in KínaRehabilitation With Wearable Monitors for Post-Lung Cancer Surgery
- Where
- Chengdu
- Életkor
- 18 év to 85 év
- People
- 126
- Run by
- West China Hospital
See details and how to joinNCT07733492 - No phaseNot yet taking people in KínaDigital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection
- Where
- Chengdu
- Életkor
- 18 év to 85 év
- People
- 222
- Run by
- West China Hospital
See details and how to joinNCT07797075 - 1. fázisTaking peopleA Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 230
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT06461156